E-Cigarette Summit 2017 – Friday 17th November | Royal Society, London

cropped-summit-logo-2017

Since the inaugural meeting in November 2013, The E-Cigarette Summit has been at the forefront of taking forward the scientific and public health debate around e-cigarettes and broader harm reduction debates. The Summit has established itself as a neutral environment for scientists, policy makers, medical and public health professionals and stakeholders to come together and look at the latest scientific research and evidence on e-cigarettes and debate their impact. In 2013, the conversation was UK centric as the public health and policy communities sought to find an appropriate regulatory system for e-cigarettes that would reflect the opportunities for smokers without ignoring potential harms. In the intervening years, the UK has emerged as an active proponent for tobacco harm reduction alongside stringent tobacco control measures and now five years on the Summit welcomes scientists, public health professionals and policy makers from around the world who are looking to establish their own regulatory framework in the face of new nicotine products.

Alongside the latest evidence on the safety of e-cigarettes for users and bystanders, The E-Cigarette Summit will continue to address broader debates including evidence on “gateway” for youth and non-smokers, advertising and marketing, use in public places and the conflicts arising from the tobacco industry’s dual corporate ownership of tobacco harm reduction products and cigarettes. The role that e-cigarettes could play in ending or extending the smoking epidemic will remain one of the most fiercely fought debates in public health history.

For governments and policy makers/advisors, the weight of making the right decision cannot be underestimated. From outright bans, advertising restrictions to higher taxation; the way that each country introduces, interprets and implements legislation, including consumer and medical licensing routes, will have far reaching consequences. Setting the regulatory bar at the correct level, will be vital to harnessing the opportunities that e-cigarettes and reduced harm nicotine products could offer while remaining responsive to a tobacco control manifesto to reduce smoking related harm.

What questions will be explored?

The E-Cigarette Summit will include high level briefings from experts and encourages interaction through panel debates and open floor discussions. Questions will be explored in a balanced and objective environment allowing attendees to build their knowledge and share their viewpoints.

This year the summit will explore the latest research and evidence on the following areas:

  • The Continuum of Harm Reduction and different policy/regulatory approaches.
  • E-Cigarette safety and research
  • Nicotine health impacts including addiction
  • Dual use – how concerned should we be?
  • Heat not Burn and E-cigarettes – similarities and differences
  • Advertising restrictions – how to reach smokers and protect youth?
  • Medicinal Licensing – is this a viable route and where are the products?
  • What does the evidence say about gateway?
  • Are there health risks through second hand vapour for non-users?
  • If e-cigarettes are so good, why aren’t all smokers using them?

Who Should Attend?

In particular, this event will be relevant to:

  • Regulators and policy advisors
  • Scientific/research community
  • Smoking cessation practitioners/services
  • Health providers, health charities and health campaigners
  • Local Authorities and Environmental Health
  • Public health professionals and academics
  • Medical and health professionals
  • e-cigarette industry and broader stakeholders groups

This years summit welcomes many researchers from around the world, including many who are part of the UKCTAS network. Including; Professor Linda Bauld from the University of Stirling, Professor Ann McNeill from King’s College London, Dr Jamie Hartmann-Boyce from the University of Oxford and Professor Robert West from University College London. The summit will also feature inputs from the Department of Health, Public Health England and many more public health organisations. To see the full list of speakers click here.

Early Bird Rates are valid until Friday 20th October!

To register for this event or to find out more information, click here!

Advertisements

Society for the Study of Addiction – Annual Conference 2017

9th – 10th November 2017
Crowne Plaza, Newcastle, UK

Confirmed sessions include:

  • Sport & exercise in addiction and recovery with personal reflections from Clarke Carlisle.
  • End of life care for people with substance problems.
  • The psychedelic renaissance in addiction treatment.
  • Pathways to amphetamine type stimulant use.

Capture.JPG


NEW for 2017: The ADDICTION DEBATE

‘This Society believes it is appropriate to expand the concept of addiction to behaviours such as internet use’

With Professor Robert West & Professor Mark Griffiths


SSA PhD Symposium 2017

New for 2017, the SSA’s PhD Symposium will be held the day before our annual Conference, in the same venue.

The SSA’s symposium for PhD students is now in its ninth year. This event aims to bring together PhD students studying addiction-related topics so they can network, present their work in a low-key, supportive environment and share their ups and downs. It welcomes full and part-time students, studying in a range of disciplines including social sciences, laboratory sciences and health services research. The day includes presentations from students at various stages in the PhD process and some close to or who have recently submitted their thesis.

There is a social event in the evening of the PhD Symposium, and throughout the day there is plenty of opportunity to talk to other delegates.

 

For more information about this event please visit: www.addiction-ssa.org/symposium

 

Tobacco Control in England: Reducing Inequalities and Improving NHS Sustainability

tc phe.jpg

Public Health England and NHS England are hosting three one-day events with a practical focus on the current challenges and how they can be met, discussing implementation of tobacco control interventions and how the NHS can make its contribution, to the benefit not only of millions of smokers but its own sustainability.

London – Tuesday 4 April

Leeds – Wednesday 26 April

Birmingham – Thursday 4 May

Smoking rates in England have been declining steadily in the general adult population in recent years (17%), falling further and faster among young people (8%). However, hidden behind this success is slower progress among certain population groups, including individuals with mental health problems and those on lower incomes. Large geographical variations also remain, including amongst women who smoke during pregnancy.

Smokers from all groups are likely to be high users of healthcare services, with significant financial and capacity related implications. Addressing this will be key to ensuring NHS sustainability.

Reducing smoking is key to ensuring NHS sustainability and with the new national CQUIN for addressing risky behaviours (alcohol and tobacco) and local Sustainability and Transformation Plans, there is a fresh impetus for collective action to reduce the health inequalities caused by smoking.

Aim:

  • to explore opportunities for action across the local system to engage with smokers and support them to quit, tackling health inequalities and reducing the burden on the NHS and social care of smoking-related disease.

Objectives:

  • identify key areas for joint action to tackle smoking and reduce health inequalities
  • understand where smokers are accessing the healthcare system and how this impacts on primary and secondary care services
  • consider the ways in which healthcare professionals can integrate treatment for tobacco dependence into routine care and support smokers to quit

Who should attend?

  • local authority and NHS commissioners
  • CCG leads for acute care, mental health and maternity
  • healthcare and service providers
  • those with responsibility for managing: Commissioning for Quality and Innovation (CQUINS), delivery of Sustainability and Transformation Plans (STPs), implementation of the stillbirth reduction care bundle
  • regional strategic leads for health improvement and clinical networks

More information and registration!

Women & Alcohol | Edinburgh and London-Based Seminar Series | 2017

The Institute of Alcohol Studies (IAS) and the Scottish Health Action on Alcohol Problems (SHAAP) are co-hosting a four part seminar series to discuss issues relating to women and alcohol.

Each session will be chaired by an eminent academic, who will invite three guest speakers to present their personal responses to three pre-set questions, which are relevant to the topic.

These events will provide an opportunity for policy makers, academics, activists, and media representatives to critically discuss topics related to women and alcohol use. The intention is to stimulate thinking, challenge some attitudes and perceptions, and to think about future research and policy priorities.

Seminar 1: Friday, 10th March 2017

Women, Alcohol, and Globalisation.
Royal College of Physicians, London, 2 – 4pm

Chair: Dr. Cecile Knai, Associate Professor of Public Health Policy, London School of Hygiene and Tropical Medicine.

  • How does alcohol marketing influence women’s behaviours?
  • How does alcohol marketing influence attitudes towards women?
  • How does alcohol affect women in different social and cultural contexts?

Continue reading